Peter D. Aplan
- Hematology top 0.2%
- Acute Myeloid Leukemia Research 65
- Chronic Myeloid Leukemia Treatments 17
- Molecular Biology top 1%
- Protein Degradation and Inhibitors 17
- Genomics and Chromatin Dynamics 16
- DNA Repair Mechanisms 14
- Epigenetics and DNA Methylation 14
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 19
- Immunology top 2%
-
- Acute Lymphoblastic Leukemia research 46
- Co-authors
- Ilan R. KirschChristopher SlapeSheryl M. GoughDavid S. ChervinskyDonald P. LombardiTrang HoangSabine HerblotC. Glenn Begley
- Cited by
- HematologyMolecular BiologyGenetics
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Peter D. Aplan
147 papers receiving 6.3k citations
Peers
Comparison fields: 5 of 111
- Hematology 2.3k
- Molecular Biology 4.4k
- Genetics 617
- Immunology 1.1k
- Public Health, Environmental and Occupational Health 1.2k
Countries citing papers authored by Peter D. Aplan
This map shows the geographic impact of Peter D. Aplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter D. Aplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter D. Aplan more than expected).
Fields of papers citing papers by Peter D. Aplan
This network shows the impact of papers produced by Peter D. Aplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter D. Aplan. The network helps show where Peter D. Aplan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter D. Aplan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 7 | |
| 4 | 2021 | 8 | |
| 5 | 2019 | 7 | |
| 6 | 2019 | 4 | |
| 7 | 2018 | 0 | |
| 8 | 2014 | 59 | |
| 9 | 2012 | 6 | |
| 10 | 2010 | 20 | |
| 11 | 2008 | 87 | |
| 12 | 2007 | 52 | |
| 13 | 2007 | 54 | |
| 14 | 2007 | 13 | |
| 15 | Generation of immortal, IL3-dependent cell lines from embryonic stem (ES) cells expressing a NUP98-HOXD13 fusion gene | 2006 | 1 |
| 16 | 2005 | 26 | |
| 17 | NUP98-Topoisomerase 1 acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutation | 2004 | 1 |
| 18 | scid Thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes. | 2001 | 18 |
| 19 | 1998 | 21 | |
| 20 | 1997 | 59 |
About Peter D. Aplan
Peter D. Aplan is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 155 papers that have together received 6.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (65 papers), Acute Lymphoblastic Leukemia research (46 papers), Chronic Lymphocytic Leukemia Research (19 papers), Protein Degradation and Inhibitors (17 papers), Chronic Myeloid Leukemia Treatments (17 papers), Genomics and Chromatin Dynamics (16 papers), DNA Repair Mechanisms (14 papers) and Epigenetics and DNA Methylation (14 papers). The work is most often cited by research in Hematology (2.3k citations), Molecular Biology (4.4k citations) and Genetics (617 citations). Peter D. Aplan has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Ilan R. Kirsch, Christopher Slape, Sheryl M. Gough, David S. Chervinsky, Donald P. Lombardi, Trang Hoang, Sabine Herblot, C. Glenn Begley, Xianfeng Zhao and Zhenhua Zhang. Their work appears in journals such as Blood, Cancer Research, Genes Chromosomes and Cancer, Molecular and Cellular Biology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.